Cargando…
Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report
Pyoderma gangrenosum is an ulcerating disease associated with a high degree of morbidity and mortality. Currently, little is known about the pathophysiology of pyoderma gangrenosum, though it has been linked to increased levels of inflammatory cytokines including interleukin-23. As pyoderma gangreno...
Autores principales: | Vallerand, Isabelle A, Hardin, Jori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498760/ https://www.ncbi.nlm.nih.gov/pubmed/31080598 http://dx.doi.org/10.1177/2050313X19845206 |
Ejemplares similares
-
Pyoderma gangrenosum treated with secukinumab: A case report
por: McPhie, Meghan L, et al.
Publicado: (2020) -
Multifocal cocaine-induced pyoderma gangrenosum: A report of two cases and review of literature
por: Lemieux, Alexandre, et al.
Publicado: (2020) -
Pyoderma gangrenosum–like ulceration of the lower extremity secondary to sunitinib therapy: a case report
por: Lopez Pineiro, Mildred, et al.
Publicado: (2018) -
A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report
por: Tai, Felicia, et al.
Publicado: (2020) -
Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum
por: Baier, Cassandra, et al.
Publicado: (2020)